BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10915651)

  • 1. Effects of M1 and CCK antagonists on latency of pancreatic amylase response to intestinal stimulants.
    Niebergall-Roth E; Teyssen S; Singer MV
    Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G411-6. PubMed ID: 10915651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV
    Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency of pancreatic enzyme response to intraduodenal stimulants.
    Singer MV; Solomon TE; Wood J; Grossman MI
    Am J Physiol; 1980 Jan; 238(1):G23-9. PubMed ID: 6153511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1550-9. PubMed ID: 9227493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
    Singer MV; Teyssen S; Küppers U
    Digestion; 1991; 48(1):34-42. PubMed ID: 1868967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion.
    Dale WE; Turkelson CM; Solomon TE
    Am J Physiol; 1989 Nov; 257(5 Pt 1):G782-90. PubMed ID: 2480719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency of pancreatic fluid secretory response to intestinal stimulants in the dog.
    Singer MV
    J Physiol; 1983 Jun; 339():75-85. PubMed ID: 6310094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of the CCK-receptor antagonist loxiglumide and the M1-receptor antagonist telenzepine on the pancreatic protein response to intraduodenal tryptophan in dogs. First results.
    Teyssen S; Singer MV
    Ann N Y Acad Sci; 1994 Mar; 713():368-71. PubMed ID: 8185190
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic bicarbonate response to intraduodenal tryptophan in dogs: role of muscarinic M1-receptors and cholecystokinin.
    Niebergall-Roth E; Teyssen S; Hartel M; Beglinger C; Riepl RL; Singer MV
    Int J Pancreatol; 1998 Feb; 23(1):31-9. PubMed ID: 9520089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal mechanism of pancreatic exocrine secretion stimulated by sodium oleate and L-tryptophan in dogs.
    Jo YH; Lee YL; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1992 Jul; 263(1 Pt 1):G12-6. PubMed ID: 1636708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and presence of the M1-receptor antagonist telenzepine.
    Teyssen S; Niebergall E; Chari ST; Singer MV
    Pancreas; 1995 May; 10(4):368-73. PubMed ID: 7792293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans.
    Nelson DK; Glasbrenner B; Dahmen G; Riepl RL; Malfertheiner P; Adler G
    Am J Physiol; 1996 Nov; 271(5 Pt 1):G824-30. PubMed ID: 8944697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure cholecystokinin: pancreatic protein and bicarbonate response.
    Debas HT; Grossman MI
    Digestion; 1973; 9(6):469-81. PubMed ID: 4787845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exocrine pancreatic secretagogues on circulating somatostatin in dogs.
    Beglinger C; Ribes G; Whitehouse I; Loubatières-Mariani MM; Grötzinger U; Gyr K
    Am J Physiol; 1986 Jan; 250(1 Pt 1):G15-20. PubMed ID: 2867683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteropancreatic reflexes mediating the pancreatic enzyme response to nutrients.
    Niebergall-Roth E; Singer MV
    Auton Neurosci; 2006 Apr; 125(1-2):62-9. PubMed ID: 16490403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of pancreatic enzyme secretion by melatonin and its precursor; L-tryptophan. Role of CCK and afferent nerves.
    Leja-Szpak A; Jaworek J; Nawrot-Porabka K; Palonek M; Mitis-Musioł M; Dembiński A; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():33-46. PubMed ID: 15608359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients.
    Yox DP; Brenner L; Ritter RC
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R554-61. PubMed ID: 1373576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.